期刊文献+

Interplay between nitric oxide and VIP in CCK-8-induced phasic contractile activity in the rabbit sphincter of Oddi 被引量:11

Interplay between nitric oxide and VIP in CCK-8-induced phasic contractile activity in the rabbit sphincter of Oddi
暂未订购
导出
摘要 AIM: The sphincter of Oddi (SO) plays an important role in delivery of bile into the duodenum. To establish whether vasoactive intestinal polypeptide (VIP) and nitric oxide (NO) were involved in phasic contractile activity of the rabbit SO stimulated by cholecystokinin-octapeptide (CCK-8). METHODS: Isolated SO muscle rings were cleaned of fat and mounted horizontally on two small L-shaped hooks one of which was connected to a force transducer for the measurement of isometric tension.The experiments were carried out in a thermostatically controlled (37±0.2℃) organ bath (5 mL) containing Krebs solution.The organ fluid was gassed with 95% O2 and 50 mL/L CO2 to keep the pH at 7.40±0.05. Contractile responses to CCK-8 (1 μmol/L) were evaluated in the presence and absence of NG-nitro-L-arginine (LNNA), an inhibitor of NO synthase (100 μmol/L), and (p-chloro-D-Phe6-Leu17)-VIP (VlPa, 30 μmol/L), a VIP receptor antagonist. RESULTS: CCK-8 stimulated the phasic activity of the SO. NO synthase inhibition increased the frequency and amplitude of contractions with a slight increase in developed tension. Pre-incubation with VlPa also attenuated this CCK-8 effect. The combined application of LNNA and VlPa abolished the phasic activity of the muscle rings with a marked increase in tension in response to CCK-8. CONCLUSION: VIP and NO together contribute to an increase in phasic activity of SO. AIM: The sphincter of Oddi (SO) plays an important role in delivery of bile into the duodenum. To establish whether vasoactive intestinal polypeptide (VIP) and nitric oxide (NO) were involved in phasic contractile activity of the rabbit SO stimulated by cholecystokinin-octapeptide (CCK-8).METHODS: Isolated SO muscle rings were cleaned of fat and mounted horizontally on two small L-shaped hooksone of which was connected to a force transducer for the measurement of isometric tension. The experiments were carried out in a thermostatically controlled (37±0.2℃)organ bath (5 mL) containing Krebs solution. The organ fluid was gassed with 95% O2 and 50 mL/L CO2 to keep the pH at 7.40±0.05. Contractile responses to CCK-8 (1μmol/L) were evaluated in the presence and absence of N^G-nitro-L-arginine (LNNA), an inhibitor of NO synthase (100μmol/L), and (p-chloro-D-Phe^6-Leu^17)-VIP (VIPa,30μmol/L), a VIP receptor antagonist.RESULTS: CCK-8 stimulated the phasic activity of the SO.NO synthase inhibition increased the frequency and amplitude of contractions with a slight increase in developed tension.Pre-incubation with VIPa also attenuated this CCK-8 effect.The combined application of LNNA and VIPa abolished the phasic activity of the muscle rings with a marked increase in tension in response to CCK-8.CONCLUSION: VIP and NO together contribute to an increase in phasic activity of SO.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第21期3264-3266,共3页 世界胃肠病学杂志(英文版)
基金 Supported by The Wellcome Trust (Grant No. 022618),by the Hungarian Scientific Research Fund (D42188, T43066 and T042589)and by the GVOP-3.2.2.-2004-07-0001/3.0
关键词 Sphincter of Oddi CCK VIP NO LNNA 一氧化氮 肠促胰酶肽-8 酶活性 动物实验 括约肌 胆汁 十二指肠
  • 相关文献

参考文献12

  • 1Toouli J, Baker RA. Innervation of the sphincter of Oddi:physiology and considerations of pharmacological intervention in biliary dyskinesia. Pharmacol Ther 1991; 49:269-281.
  • 2Pauletzki JG, Sharkey KA, Davison DS, Bomzon A, Shaffer EA. Involvement of L-arginine-nitric oxide pathways in neural relaxation of the sphincter of Oddi. Eur J Pharmacol 1993; 232:263-270.
  • 3Wiley JW, O'Dorioso TM, Owyang C. Vasoactive intestinal polypeptide mediates cholecystokinin-induced relaxation of the sphincter of Oddi. J Clin Invest 1988; 81:1920-1924.
  • 4Lonovics J, Jakab I, Szilvassy J, Szilvassy Z. Regional differences in nitric oxide-mediated relaxation of the rabbit sphincter of Oddi. Eur J Pharmacol 1994; 255:117-122.
  • 5Slivka A, Chuttani R, Carr-Locke DL, Kobzik L, Bredt DS,Loscalzo J, Stamler JS. Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest 1994; 94:1792-1798.
  • 6Moncada S, Palmer RM, Higgs EA. Nitric oxide:physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
  • 7Allescher HD, Kurjak M, Huber A, Trundrung P, Schusdzierra V. Regulation of VIP release from rat enteric nerve terminals:evidence for a stimulatory effect of NO. Am J Physiol 1996;271:G568-G574.
  • 8Vergara P, Woskowska Z, Cipris S, Fox-Threlkeld JE, Daniel EE. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide, f Pharmacol Exv Ther 1996,279:306-316.
  • 9Lonovics J, Lenart Z, Velosy B, Nemeth J, Varro V, Thompson JC. Differences in the mechanism cholecystokinin, substance P, and vasoactive intestinal polypeptide induced sphincter of Oddi relaxation in dogs. In: Peptides Chemistry, biology, interaction with proteins. Penke B, Torok A, ed. New York: Walter de Gruuter 1988,171-174.
  • 10Behar J, Biancani P. Effect of cholecystokinin and the octapeplkie of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action. J Clin Invest 1980; 66:1231-1239.

同被引文献96

引证文献11

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部